<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01415024</url>
  </required_header>
  <id_info>
    <org_study_id>BO/01/2011</org_study_id>
    <nct_id>NCT01415024</nct_id>
  </id_info>
  <brief_title>Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication</brief_title>
  <acronym>CRTICD Dual LV</acronym>
  <official_title>Resynchronization in Paced Heart Failure Patients With ICD Indication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Schuechtermann-Klinik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Schuechtermann-Klinik</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Today patients with a Cardiac Resynchronization Therapy (CRT) indication usually receive 2
      ventricular leads, right ventricular (RV) apex and left ventricular (LV) (postero-) lateral,
      gaining a responder rate of approximately 70%. However, the physiological agitation of the
      left ventricle takes place over two pathways. Therefore single point stimulation might be
      insufficient for a dilated, insufficiently and asynchronously contracting left ventricle,
      resulting in either insufficient or no response to the therapy.

      In the &quot;CRT ICD Dual LV&quot; study the patients receive a second LV lead in an anterior vein.
      When this lead is placed, temporary dual LV stimulation is started. To assess the effectivity
      of the dual LV lead stimulation intraoperatively a LV dp/dt-pressure measurement is taken. If
      there is an increase in LV dp/dt, the patients will be stimulated with both leads
      permanently. If not they will be stimulated conventionally.

      The patients participating in this study are monitored for 12 months after implantation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <primary_completion_date type="Anticipated">May 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LV dp/dt pressure during dual LV CRT stimulation vs. conventional biventricular pacing</measure>
    <time_frame>Implantation with pressure measurement will take place in the first week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leftventricular endsystolic volume</measure>
    <time_frame>12 month</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <condition>Left Bundle-Branch Block</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>second LV lead in CRT</intervention_name>
    <description>second LV lead in CRT</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  EF less than 35 percent

          -  CAD or dilatative Cardiomyopathy

          -  Sinus rhythm

          -  NYHA III or IV, stable recompensated

          -  QRS more than 120ms

          -  LBBB

          -  Patient signed Consent Form

          -  Age more than 18 and less than 80 y

        Exclusion Criteria:

          -  permanent atrial Fibrillation

          -  permanent AV-Block II or III

          -  Tricuspidal- and or artificial aortic valve

          -  Indication for ACB or ACB less than 3 months ago

          -  myocardial infarction less than 3 months

          -  hypertrophic obstructive Cardiomyopathy; constrictive Pericarditis

          -  heartfailure with iv catecholamine therapy

          -  Manifested, uncontrolled, Hypo- oder Hyperthyreosis

          -  Severe renal insufficiency with Creatinine more than 2,5 mg per dL

          -  patients, who did not sign the consent form

          -  General medical conditions, which restrict the patient compliance

          -  Participation in another study

          -  life expectancy less than 1 y

          -  Age less than 18 y or more than 80y

          -  Pregnant women or Women of childbearing age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Kranig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Schuechtermann-Klinik</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wolfgang Kranig, MD</last_name>
    <phone>+49-5424-6410</phone>
    <email>wkranig@schuechtermann-klinik.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rainer Grove, MD</last_name>
    <phone>+49-5424-6410</phone>
    <email>rgrove@schuechtermann-klinik.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Schuechtermann-Klinik</name>
      <address>
        <city>Bad Rothenfelde</city>
        <state>Niedersachsen</state>
        <zip>49214</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Kranig, MD</last_name>
      <phone>+49-5424-6410</phone>
      <email>wkranig@schuechtermann-klinik.de</email>
    </contact>
    <contact_backup>
      <last_name>Rainer Grove, MD</last_name>
      <phone>+49-5424-6410</phone>
      <email>rgrove@schuechtermann-klinik.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2011</study_first_submitted>
  <study_first_submitted_qc>August 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2011</study_first_posted>
  <last_update_submitted>August 10, 2011</last_update_submitted>
  <last_update_submitted_qc>August 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. med. Wolfgang Kranig</name_title>
    <organization>Schuechtermann- Klinik</organization>
  </responsible_party>
  <keyword>CRT</keyword>
  <keyword>Dual LV</keyword>
  <keyword>Triple Ventricle stimulation</keyword>
  <keyword>two leftventricular leads</keyword>
  <keyword>Av VV optimization</keyword>
  <keyword>Lv dp/dt measurement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Bundle-Branch Block</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

